Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Papeix

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Neurology|March 17, 2026
Frequency of AQP4 and MOG Antibodies in Patients With Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI CriteriaRomain Deschamps, Caroline Papeix, Sarah Demortiere, et al.
Neurology|February 25, 2021
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica DisorderNicolas Collongues, Cecilia Alves Do Rego, Bertrand Bourre, et al.
Journal of Neurology|October 27, 2025
Rethinking routine lumbar puncture in isolated optic neuritis: results from a large cohort studyRomain Deschamps, Marine Boudot de la Motte, Emeline Chaugne, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
Journal of Virology|March 22, 2013
Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapyHouria Hendel-Chavez, Marie-Ghislaine de Goër de Herve, Claire Giannesini, et al.
Neurology|February 9, 2021
Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSDHelene Zephir, Julien Poupart, Romain Deschamps, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 3, 2021
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersCéline Louapre, Michella Ibrahim, Elisabeth Maillart, et al.
Neurology|June 8, 2023
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum DisorderStanislas Demuth, Nicolas Collongues, Bertrand Audoin, et al.
Annals of Neurology|February 19, 2016
Dynamic Imaging of Individual Remyelination Profiles in Multiple SclerosisBenedetta Bodini, Mattia Veronese, Daniel García-Lorenzo, et al.
Multiple Sclerosis and Related Disorders|February 28, 2026
Risk of postpartum disease activity with subcutaneous versus intravenous Natalizumab in pregnant women with multiple sclerosisVito Ag Ricigliano, Doriana Landi, Marine Boudot de la Motte, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Neurology|March 17, 2026
Frequency of AQP4 and MOG Antibodies in Patients With Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI CriteriaRomain Deschamps, Caroline Papeix, Sarah Demortiere, et al.
Neurology|February 25, 2021
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica DisorderNicolas Collongues, Cecilia Alves Do Rego, Bertrand Bourre, et al.
Journal of Neurology|October 27, 2025
Rethinking routine lumbar puncture in isolated optic neuritis: results from a large cohort studyRomain Deschamps, Marine Boudot de la Motte, Emeline Chaugne, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
Journal of Virology|March 22, 2013
Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapyHouria Hendel-Chavez, Marie-Ghislaine de Goër de Herve, Claire Giannesini, et al.
Neurology|February 9, 2021
Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSDHelene Zephir, Julien Poupart, Romain Deschamps, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 3, 2021
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersCéline Louapre, Michella Ibrahim, Elisabeth Maillart, et al.
Neurology|June 8, 2023
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum DisorderStanislas Demuth, Nicolas Collongues, Bertrand Audoin, et al.
Annals of Neurology|February 19, 2016
Dynamic Imaging of Individual Remyelination Profiles in Multiple SclerosisBenedetta Bodini, Mattia Veronese, Daniel García-Lorenzo, et al.
Multiple Sclerosis and Related Disorders|February 28, 2026
Risk of postpartum disease activity with subcutaneous versus intravenous Natalizumab in pregnant women with multiple sclerosisVito Ag Ricigliano, Doriana Landi, Marine Boudot de la Motte, et al.
Pageof 16